Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315I-Reference-Cited by-同舟云学术

Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315I

Published:2010-05-05 Issue:15 Volume:116 Page:3631-3637
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Velev Nikolai,Cortes Jorge,Champlin Richard,Jones Dan,Rondon Gabriela,Giralt Sergio,Borthakur Gautam,Kantarjian Hagop M.,De Lima Marcos

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.25092/fullpdf

Reference30 articles.

1. In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants;O'Hare;Cancer Res.,2005

2. Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib;Hochhaus;Leukemia.,2008

3. Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance;Kantarjian;Blood.,2007

4. Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia;Apperley;Lancet Oncol.,2007

5. Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors;Cortes;Blood.,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guidelines for the treatment of chronic myeloid leukemia from the NCCN and ELN: differences and similarities;International Journal of Hematology;2022-09-05

2. Recent advances in Bcr‐Abl tyrosine kinase inhibitors for overriding T315I mutation;Chemical Biology & Drug Design;2020-10-29

3. Chronic Myeloid Leukemia;Holland-Frei Cancer Medicine;2016-10-31

4. Unexpected Success of Watch and Wait Strategy in a Ponatinib-Intolerant Patient With Chronic Myeloid Leukemia;Journal of Oncology Practice;2016-06

5. Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia;Biology of Blood and Marrow Transplantation;2016-06